Lapatinib ditosylate

Lapatinib is a tyrosine kinase receptor inhibitor used in the therapy of advanced breast cancer and other solid tumors. Lapatinib therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent acute liver injury.

Price Not Available 100 mg Lapatinib ditosylate Supplier Page

Catalog Number	T0078L
Alternative Name(s)	Tykerb , Tyverb , Lapatinib ditosylate monohydrate , Lapatinib ditoluenesulfonate monohydrate , Lapatinib tosilate hydrate , Lapatinib tosilate
Research Area	Tyrosine Kinase/Adaptors\|\|\|Angiogenesis\|\|\|JAK/STAT signaling\|\|\|Apoptosis\|\|\|Autophagy
Molecular Formula	C29H26ClFN4O4S·2(C7H8O3S)·H2O
CAS#	388082-78-8
SMILES	n1cnc(c2cc(ccc12)c1oc(cc1)CNCCS(=O)(=O)C)Nc1cc(c(cc1)OCc1cc(ccc1)F)Cl.c1(ccc(cc1)C)S(=O)(=O)O.O.c1(ccc(cc1)C)S(=O)(=O)O
Size	100 mg
Supplier Page	https://www.targetmol.com/compound/Lapatinib ditosylate monohydrate
Additional Information	https://www.targetmol.com/datasheet/T0078L